Related Experiment Video
Updated: Apr 20, 2026

A Web-Based Workflow for Selecting Gene- and Tissue-Specific Enhancers
Published on: July 18, 2025
Can genome engineering be used to target cancer-associated enhancers?
Matthew R Grimmer1, Peggy J Farnham
1Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089-9601, USA.
Abstract:
Transcriptional misregulation is involved in the development of many diseases, especially neoplastic transformation. Distal regulatory elements, such as enhancers, play a major role in specifying cell-specific transcription patterns in both normal and diseased tissues, suggesting that enhancers may be prime targets for therapeutic intervention. By focusing on modulating gene regulation mediated by cell type-specific enhancers, there is hope that normal epigenetic patterning in an affected tissue could be restored with fewer side effects than observed with treatments employing relatively nonspecific inhibitors such as epigenetic drugs. New methods employing genomic nucleases and site-specific epigenetic regulators targeted to specific genomic regions, using either artificial DNA-binding proteins or RNA-DNA interactions, may allow precise genome engineering at enhancers. However, this field is still in its infancy and further refinements that increase specificity and efficiency are clearly required.
Insights
Transcriptional misregulation drives diseases like cancer. Targeting cell-specific enhancers offers a precise therapeutic strategy to restore normal gene regulation with potentially fewer side effects than broad epigenetic drugs.
Area of Science:
- Genetics
- Epigenetics
- Molecular Biology
Background:
- Transcriptional misregulation is a key factor in disease development, particularly in neoplastic transformation.
- Cell type-specific enhancers are crucial for controlling gene expression patterns in normal and diseased tissues.
- Enhancers represent promising targets for novel therapeutic interventions.
Purpose of the Study:
- To explore the potential of targeting cell type-specific enhancers for therapeutic intervention.
- To investigate methods for precise genome engineering at enhancer regions.
- To highlight the need for increased specificity and efficiency in enhancer-targeting technologies.
Main Methods:
- Utilizing genomic nucleases for targeted modifications.
- Employing site-specific epigenetic regulators.
- Leveraging artificial DNA-binding proteins and RNA-DNA interactions for precise targeting.
Main Results:
- Demonstrated the role of enhancers in cell-specific gene regulation.
- Showcased potential for precise genome engineering at enhancers.
- Identified the early stage of development for this therapeutic approach.
Conclusions:
- Modulating gene regulation via cell type-specific enhancers offers a promising therapeutic avenue.
- Precise genome engineering at enhancers could restore normal epigenetic patterns with reduced side effects.
- Further advancements in specificity and efficiency are crucial for clinical application.
More Related Videos
Related Concept Videos
What is Genetic Engineering?
Epigenetic Regulation
X-chromosome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
In-vitro Mutagenesis
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

